INHIBITOR OF THE MUTANT FORM OF KIT

摘要

PROBLEM TO BE SOLVED: To provide inhibitors of mutant KIT effective even for KIT (a receptor protein tyrosine kinase) dependent diseases which are resistant to treatment with imatinib. SOLUTION: The present invention relates to the use of an appropriate inhibitor of mutant KIT for the manufacture of a medicament for treating a KIT dependent disease in a patient, selected from the group consisting of midostaurin, vatalanib, and a compound of formula (A). COPYRIGHT: (C)2011,JPO&INPIT